• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Becton, Dickinson and Company (BDX)

    -NYSE
    139.81 0.62(0.44%) Dec 19, 4:04PM EST
    Add to Portfolio
    Prev Close:140.43
    Open:140.79
    Bid:132.34 x 100
    Ask:147.64 x 100
    1y Target Est:145.17
    Beta:1.11
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:139.49 - 141.44
    52wk Range:105.21 - 142.56
    Volume:1,545,345
    Avg Vol (3m):1,617,220
    Market Cap:26.84B
    P/E (ttm):23.34
    EPS (ttm):5.99
    Div & Yield:2.40 (1.80%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BDX

    Comparison

    Symbol% ChgMkt Cap
    BDXDown 0.44%26.84B
    ABT69.34B
    BAX40.37B
    COV46.59B

    Key Statistics

    Forward P/E (1 yr):19.20
    P/S (ttm):3.20
    Ex-Dividend Date:08-Dec-14

    Analysts

    Annual EPS Est (Sep-15) :6.80
    Quarterly EPS Est (Dec-14) :1.45
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):2.86

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback